These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33150072)

  • 21. TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Wang V; Heffer A; Roztocil E; Feldon SE; Libby RT; Woeller CF; Kuriyan AE
    PLoS One; 2022; 17(9):e0271950. PubMed ID: 36048826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells.
    Obermann J; Priglinger CS; Merl-Pham J; Geerlof A; Priglinger S; Götz M; Hauck SM
    Mol Cell Proteomics; 2017 Aug; 16(8):1528-1546. PubMed ID: 28576849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation.
    Miao Q; Xu Y; Yin H; Zhang H; Ye J
    J Cell Mol Med; 2020 Mar; 24(5):3217-3228. PubMed ID: 32022439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Pan J; Zhao LX
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4627-4634. PubMed ID: 32432726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy.
    Kaneko H; Terasaki H
    Transl Vis Sci Technol; 2017 Jul; 6(4):5. PubMed ID: 28706757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intervention of epithelial-mesenchymal transition in homeostasis of human retinal pigment epithelial cells: a review.
    Gelat B; Rathaur P; Malaviya P; Patel B; Trivedi K; Johar K; Gelat R
    J Histotechnol; 2022 Dec; 45(4):148-160. PubMed ID: 36377481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Epithelial-Mesenchymal Transition and Prevention of Dispase-Induced PVR by Delivery of an Antioxidant αB Crystallin Peptide.
    Wada I; Sreekumar PG; Spee C; MacKay AJ; Ip M; Kannan R
    Antioxidants (Basel); 2022 Oct; 11(10):. PubMed ID: 36290802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TSPAN4-positive migrasome derived from retinal pigmented epithelium cells contributes to the development of proliferative vitreoretinopathy.
    Wu L; Yang S; Li H; Zhang Y; Feng L; Zhang C; Wei J; Gu X; Xu G; Wang Z; Wang F
    J Nanobiotechnology; 2022 Dec; 20(1):519. PubMed ID: 36494806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.
    Zhang P; Zhao G; Ji L; Yin J; Lu L; Li W; Zhou G; Chaum E; Yue J
    Biochem Biophys Res Commun; 2018 Apr; 498(3):573-578. PubMed ID: 29522718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal Transition.
    Yao H; Li H; Yang S; Li M; Zhao C; Zhang J; Xu G; Wang F
    Sci Rep; 2016 Sep; 6():32182. PubMed ID: 27586653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1.
    Dvashi Z; Goldberg M; Adir O; Shapira M; Pollack A
    PLoS One; 2015; 10(4):e0122229. PubMed ID: 25849436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
    Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
    Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
    Casaroli-Marano RP; Pagan R; Vilaró S
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3.
    He H; Kuriyan AE; Su CW; Mahabole M; Zhang Y; Zhu YT; Flynn HW; Parel JM; Tseng SC
    Sci Rep; 2017 Mar; 7():43736. PubMed ID: 28252047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
    Heffer AM; Wang V; Libby RT; Feldon SE; Woeller CF; Kuriyan AE
    PLoS One; 2020; 15(12):e0243626. PubMed ID: 33347461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LYTAK1, a TAK1 inhibitor, suppresses proliferation and epithelial‑mesenchymal transition in retinal pigment epithelium cells.
    Chen Z; Mei Y; Lei H; Tian R; Ni N; Han F; Gan S; Sun S
    Mol Med Rep; 2016 Jul; 14(1):145-50. PubMed ID: 27175834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSK3β inhibits epithelial-mesenchymal transition
    Zhang C; Su L; Huang L; Song ZY
    Int J Ophthalmol; 2018; 11(7):1120-1128. PubMed ID: 30046527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
    Datlibagi A; Zein-El-Din A; Frohly M; Willermain F; Delporte C; Motulsky E
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.
    Priglinger CS; Obermann J; Szober CM; Merl-Pham J; Ohmayer U; Behler J; Gruhn F; Kreutzer TC; Wertheimer C; Geerlof A; Priglinger SG; Hauck SM
    PLoS One; 2016; 11(1):e0146887. PubMed ID: 26760037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.